Bristol-Myers Squibb Company Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (55)

Latest Posts

About This Stock More About This Stock
Bristol-Myers Squibb Co. Ups Forecast As Q1 Earnings Beat The Street
Article By: Lorimer Wilson
Thursday, April 27, 2017 11:27 AM EDT
Bristol-Myers Squibb Co. early Thursday posted much better than expected first quarter earnings results and lifted its full-year outlook, as sales of several of its new drugs begin to skyrocket.
In this article: BMY
Read
Biotechs Running Again: Life Science Stocks
Article By: Rod Raynovich
Tuesday, April 25, 2017 11:59 PM EDT
Biotechs are running again taking the cue from Nasdaq which is up 3.44% in April after a brief mid-month sell-off. Biotech stocks rallied from global macro concerns which has dampened investor enthusiasm over the past two months.
In this article: BMY, FBIOX, IBB, QQQ, AMGN, GILD, XBI, XLV, ABBV, BLUE, FMI Also: RHHBY, BIIB
Read
18 Drugs To Lose Patents In 2017; Could Jeopardize $26.5B For Big Pharma
Article By: Lorimer Wilson
Saturday, April 22, 2017 8:24 PM EDT
With 18 branded drugs on the line, patent losses this year could jeopardize $26.5 billion in annual sales from Big Pharma, projected to be the biggest fall-off until at least 2025.
In this article: AZN, BMY, GSK, LLY, MRK, PFE, SNY, RHHBY, TEVA
Read
Pharma Stock Roundup: Merck Gets CRL For Label Expansion Effort, Roche Cancer Drug Tops
Article By: Arpita Dutt
Friday, April 14, 2017 12:00 PM EDT
It was a relatively slow week with key highlights including a complete response letter (CRL) for Merck’s label expansion efforts for its diabetes drugs and positive data on Roche’s lung cancer treatment.
In this article: AZN, JNJ, MRK, MYL, RHHBY, PFE, BMY
Read
Bristol-Myers Squibb To Out-License Drugs To Roche & Biogen For A Total Of $470 Million In Cash
Article By: Lorimer Wilson
Thursday, April 13, 2017 2:21 PM EDT
Bristol-Myers Squibb Co. has forged a pair of separate pacts with Roche Holding Ltd. & Biogen Inc. to out-license two drugs, grabbing a whopping $470 million upfront for the deals, another $615 million in possible milestone payouts plus royalties.
In this article: BMY, BIIB, RHHBY
Read

PARTNER HEADLINES

Latest Tweets for $BMY

No tweets yet!